NCT00752622 Treatment With Infliximab in a Medical Setting (Study P05587) Status TERMINATED Phase PHASE4
NCT00740103 Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's Disease Status COMPLETED Phase PHASE2
NCT00739986 Semapimod for Treatment of Moderate to Severe Crohn's Disease 1 or 3 Days' Treatment Versus Placebo Status COMPLETED Phase PHASE2
NCT00731809 Evaluation of PET CT in the Management of Patients With Crohn's Disease. Status UNKNOWN Phase PHASE4
NCT00727298 Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840) Status COMPLETED Phase N/A
NCT00724958 Program Extension of Real Life Dosing of Remicade in Austria for Crohn's Disease (Study P04052)(COMPLETED) Status COMPLETED Phase N/A
NCT00723840 Assessment of the Social Cost of Crohn's Disease: Economic and Quality of Life Aspects (Study P04560) Status COMPLETED Phase N/A
NCT00723047 Fibrin Glue for Perianal Fistulas in Crohn's Disease: a Randomized Controlled Trial Status COMPLETED Phase PHASE3
NCT00715117 The Efficacy of Low Dose Naltrexone Therapy in Children With Crohn's Disease Status COMPLETED Phase PHASE2
NCT00707512 CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring Status TERMINATED Phase N/A
NCT00705614 Postmarketing Safety Surveillance European Registry of Crohn's Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035) Status COMPLETED Phase N/A
NCT00692939 Autologous Stem Cell Transplantation for Crohn's Disease Status RECRUITING Phase PHASE1/PHASE2
NCT00688636 Infliximab for the Prevention of Recurrent Crohn's Disease After Surgery Status COMPLETED Phase PHASE4
NCT00686374 Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806 Status COMPLETED Phase PHASE3